Test trial of spike-in immunoglobulin heavy-chain (IGH) controls for next generation sequencing quantification of minimal residual disease in acute lymphoblastic leukaemia.
Guilherme Navarro Nilo GiustiPatrícia Yoshioka JottaCaroline de Oliveira LopesMonica Aparecida GanazzaAmilcar Cardoso de AzevedoSílvia Regina BrandaliseJoão MeidanisJosé Andres YunesPublished in: British journal of haematology (2020)